April 29, 2020 / 9:55 AM / a month ago

BRIEF-Shanghai Fosun Pharmaceutical Says Qtrly Net Profit Attributable RMB577.2 Mln

April 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* QTRLY NET PROFIT ATTRIBUTABLE RMB577.2 MILLION VERSUS RMB 712.3 MILLION

* QTRLY OPERATING REVENUE RMB5.88 BILLION VERSUS RMB6.73 BILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below